رفتن به محتوا

تداخل‌های دارویی

Enzalutamide + Erdafitinib

شدت: شدید

Enzalutamide and Erdafitinib: major interaction.

آخرین به‌روزرسانی

ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.

محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.

خلاصه

Enzalutamide is a strong CYP3A4 inducer and also induces CYP2C9. Erdafitinib is cleared by CYP2C9 and CYP3A4, so exposure may fall and its antitumor effect may be reduced.

معنای این تداخل به زبان ساده

Enzalutamide and Erdafitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Enzalutamide belongs to Endocrine; Erdafitinib belongs to Oncology.

سطح شواهد: Moderate

چرا رخ می‌دهد

Induction of CYP3A4 and CYP2C9 by enzalutamide increases erdafitinib clearance.

اقدام لازم

Avoid coadministration where possible and consider an alternative to enzalutamide. If unavoidable, monitor serum phosphate and treatment response, as erdafitinib dosing is guided by phosphate and tolerability.

از داروساز چه بپرسید

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

ویژه اعضای Pro+

باز کردن کل صفحه

یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Enzalutamide و Erdafitinib، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.

پرسش‌های متداول

Can I take Enzalutamide with Erdafitinib?

MediHelp rates the interaction as major. Enzalutamide and Erdafitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Enzalutamide is a strong CYP3A4 inducer and also induces CYP2C9. Erdafitinib is cleared by CYP2C9 and CYP3A4, so exposure may fall and its antitumor effect may be reduced.

How serious is the interaction between Enzalutamide and Erdafitinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid coadministration where possible and consider an alternative to enzalutamide. If unavoidable, monitor serum phosphate and treatment response, as erdafitinib dosing is guided by phosphate and tolerability.

What other medicines interact with Enzalutamide?

MediHelp also lists interactions of Enzalutamide with, for example, Doravirine, Elbasvir / grazoprevir, Ensitrelvir. The full list is on the Enzalutamide page.

تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp

مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.

مرور از A تا Z · تداخل‌های دارویی

دریافت برنامه ورود